Benjamin Burnett
Stock Analyst at Stifel
(1.61)
# 3,251
Out of 4,931 analysts
68
Total ratings
41.67%
Success rate
-6.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.00 | +200.00% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $55.01 | -10.93% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $68.91 | +77.04% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $17.60 | +292.05% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $22.28 | +205.21% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.06 | +333.96% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $10.78 | +433.40% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $4.62 | +16,783.12% | 2 | Sep 10, 2021 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $35.86 | +78.47% | 5 | Apr 1, 2025 | |
| IRON Disc Medicine | Maintains: Buy | $90 → $94 | $56.74 | +65.67% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.53 | +161.44% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.85 | +442.01% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.63 | +850.57% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $330 → $360 | $21.96 | +1,539.34% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.50 | +3,100.64% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.00
Upside: +200.00%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $55.01
Upside: -10.93%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $68.91
Upside: +77.04%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $17.60
Upside: +292.05%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $22.28
Upside: +205.21%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.06
Upside: +333.96%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $10.78
Upside: +433.40%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.62
Upside: +16,783.12%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $35.86
Upside: +78.47%
Disc Medicine
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $56.74
Upside: +65.67%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.53
Upside: +161.44%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.85
Upside: +442.01%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $2.63
Upside: +850.57%
Jun 28, 2021
Upgrades: Buy
Price Target: $330 → $360
Current: $21.96
Upside: +1,539.34%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.50
Upside: +3,100.64%